Observations placeholder

The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach

Identifier

022060

Type of Spiritual Experience

Background

A description of the experience

Phytomedicine. 2005 Sep;12(9):619-24.  The efficacy of Liv-52 on liver cirrhotic patients: a randomized, double-blind, placebo-controlled first approach.  Huseini HF1, Alavian SM, Heshmat R, Heydari MR, Abolmaali K.      1Department of Pharmacology, Institute of Medicinal Plants, No. 97, Bozorgmehr St., Ghods St., Enghelab Ave., Tehran, Iran. huseini_fallah@yahoo.com

Cirrhosis is the irreversible sequel of various disorders that damage liver cells permanently over time.

Presently, the use of herbal medicines for prevention and control of chronic liver diseases is the focus of attention for both the physicians and the patients; the reasons for such shift toward the use of herbals include

  • the expensive cost of conventional drugs,
  • adverse drug reactions, and
  • their inefficacy.

In the present study, the efficacy of herbal medicine Liv-52 consisting of

  • Mandur basma – [Mandur Bhasma is an Ayurvedic medicine]
  • Tamarix gallica - the French tamarisk and herbal extracts of
  • Capparis spinosa,  - Caper
  • Cichorium intybus, - Common chicory
  • Solanum nigrum, - European black nightshade
  • Terminalia arjuna - arjuna or arjun tree in English, thella maddi in Telugu, kumbuk in Sinhala, and marudha maram in Tamil and
  • Achillea millefolium - Yarrow

on liver cirrhosis outcomes was compared with the placebo for 6 months in 36 cirrhotic patients referred to Tehran Hepatic Center. The outcome measures included child-pugh score, ascites, serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), total billirubin, albumin, prothrombin time, platelet and white blood cells counts.

The indices were recorded in all patients before and after 6 months of drug or placebo treatment.

The results demonstrated that the patients treated with Liv-52 for 6 months had significantly better child-pugh score, decreased ascites, decreased serum ALT and AST.

 In placebo administered patients all the clinical parameters recorded at beginning of the study were not significantly different than after 6 months.

We conclude that Liv-52 possess hepatoprotective effect in cirrhotic patients. This protective effect of Liv-52 can be attributed to the diuretic, anti-inflammatory, anti-oxidative, and immunomodulating properties of the component herbs.

PMID: 16194047

The source of the experience

PubMed

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Commonsteps

References